Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $29.18. The company's market cap stands at 166.3B, with a P/E ratio of 42.73 and a dividend yield of 5.76%.
On 2026-11-06, Pfizer(PFE) stock moved within a range of $28.54 to $29.28. With shares now at $29.18, the stock is trading +2.2% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 15.85M, compared to an average daily volume of 39.46M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $31.44 and a low of $23.62.
PFE News
Pfizer (NYSE:PFE) CEO used a recent investor appearance to set out a plan for a renewed push into obesity treatments. Management highlighted the historic comme...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Study Overview: Pfizer’s Phase 3 study, officially titled ‘A PHASE 3 STUDY TO EVALUATE TH...
Can a growth-oriented biotech giant outpace a value-leaning pharmaceutical titan? Choosing between Amgen Inc. (AMGN -0.79%) and Pfizer Inc. (PFE +0.93%) require...
Analyst ratings
62%
of 29 ratingsMore PFE News
Pfizer stock closed at US$30.79 on Wednesday, up 2.6% on the day, as traders reacted quickly to a cleaner third quarter 2026 profit story. The jump in price cap...
On its third-quarter 2026 earnings call, held on Nov. 3, 2026, Pfizer (PFE -2.19%) raised its full-year revenue outlook to a range of $62 billion to $64 billion...
On CNBC’s “Halftime Report Final Trades,” Joshua Brown, co-founder and CEO of Ritholtz Wealth Management, picked Amazon.com, Inc. (NASDAQ:AMZN). On the earning...
Pfizer Inc ((PFE)) has held its Q3 earnings call. Read on for the main highlights of the call. Pfizer’s earnings call carried a strongly positive tone, with ma...
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 1% on Tuesday. The Dow traded down 0.46% to 51,744.97 while the NASDAQ...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Pfizer’s New Cancer Study Keeps Investors Watching the Pipeline Study Overview: Pfizer i...
Pfizer Inc. (NYSE:PFE) on Tuesday reported third-quarter sales of $16.58 billion, beating the consensus of $15.87 billion. The company said revenues came in ah...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.